Innovative Solutions in Haemato-Oncology
At myleukaemia, we revolutionize cancer treatment through precision oncology, providing tailored therapy testing for better patient outcomes and faster clinical decisions.
150+
15
Trusted by Experts
Patient-Centric
Innovative Oncology Solutions
Transforming patient care through advanced precision oncology techniques and technology.
Personalized Treatment Plans
Tailored therapies based on individual patient cell analysis.
Rapid Decision Reports
Receive clinician-ready reports within 72 hours for timely treatment decisions.
Streamlined workflows designed for tumor boards and routine lab processes.
Collaborative Partnerships
MYCancer. All rights reserved. © 2026
Subscribe to our newsletter
No Spam. Just occasional product updates & events.
Company
About
Careers
News & Press
Contact
Campus da Penteada, 9020-105 Funchal, Portugal ·
How to Join Us:
Start a Pilot
Request Study Design
Request Data Room
For Research Use Only. MYLeukaemia is an R&D-stage bone-marrow-on-chip platform. It is not CE-marked as an in vitro diagnostic medical device and is not intended for diagnosis, clinical assessment, patient management or treatment selection. Any future clinical use is subject to analytical and clinical validation and the applicable regulatory conformity route.
